Search

everythinglearnresearchcommunity

for

Search:↓

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Some alternative treatments for hair loss might work, but more research is needed.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Photodynamic therapy with methyl 5-aminolevulinic acid is ineffective for treating alopecia totalis.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Nanoemulsions improve stability and delivery of active ingredients in cosmetics for skin and hair care.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Alopecia areata involves immune response and gene changes affecting hair loss.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Personalized treatment plans are important for people with alopecia areata.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Different treatments for alopecia areata have unpredictable results and varying success rates.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.